Arrivent Biopharma, Inc. · NASDAQ:AVBP
BlackRock, Inc.'s stake in Arrivent Biopharma, Inc. fell to 4.90% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Oct 17, 2025
BlackRock, Inc.'s stake in Arrivent Biopharma, Inc. fell to 4.90%, 2,007,338 shares, as a passive investor on Sep 30, 2025. Filed Oct 17, 2025 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 2,007,338
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.90% | 2,007,338 |
Source
Related
- Arrivent Biopharma, Inc.
- BlackRock, Inc.
- Arrivent Biopharma, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G · BlackRock, Inc. · Jan 21, 2026
- Schedule 13G · Vivo Opportunity, LLC · Oct 13, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Oct 8, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · Sofinnova Venture Partners IX, L.P. ("SVP IX") · Mar 5, 2026
- Schedule 13G/A · Hillhouse Investment Management, Ltd. · Feb 17, 2026